Results 201 to 210 of about 342,290 (286)
Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells. [PDF]
Li J, Zhou W, Wang W.
europepmc +1 more source
A multivalent antiviral platform based on honeycomb‐shaped DNA nanostructures (HC–Urumin) is developed to enhance the potency and breadth of the host defense peptide Urumin. Through spatially patterned trimeric presentation, HC–Urumin disrupts influenza A virus entry, improves cell viability, and reduces disease severity in vivo‐offering a modular and ...
Saurabh Umrao +11 more
wiley +1 more source
Author Correction: Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals. [PDF]
Connors J +13 more
europepmc +1 more source
CD4+ T cells undergoing latency reversal induced by antigen-presenting dendritic cells display unique transcriptomic and TCR profiles 4359 [PDF]
Allison E. DePuyt +8 more
openalex +1 more source
A bimetallic Mn–Ca nanoreactor (MCC) is developed as a non‐nucleotide STING nanoagonist for cancer metalloimmunotherapy. MCC induces Ca2+ overload and hydroxyl radical generation, resulting in mitochondrial damage and mtDNA release. The released mtDNA cooperates with Mn2+ to robustly activate cGAS–STING signaling.
Xin Wang Mo +7 more
wiley +1 more source
Myeloid antigen-presenting cells in neurodegenerative diseases: a focus on classical and non-classical MHC molecules. [PDF]
Afify R +3 more
europepmc +1 more source
Mature dendritic cells use endocytic receptors to capture and present antigens
Craig D. Platt +7 more
openalex +1 more source
Metabolic changes in immune cells direct the phenotype and function of the host immune system. Smart nanomaterials must target metabolic pathways to direct immune cell fate. This study reports the fabrication and first application of germanane quantum dots (GeHQDs) to modulate inflammation in vitro and in vivo.
Abhay Srivastava +7 more
wiley +1 more source
MHC class I trafficking signal improves induction of cytotoxic T lymphocyte using artificial antigen presenting cells. [PDF]
Sasaki K +14 more
europepmc +1 more source

